Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Additional Paid-In Capital : ¥0.0 Mil(As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Hunan Jingfeng Pharmaceutical Co Additional Paid-In Capital?

Hunan Jingfeng Pharmaceutical Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0.0 Mil) to Dec. 2023 (¥1,016.9 Mil) but then stayed the same from Dec. 2023 (¥1,016.9 Mil) to Mar. 2024 (¥0.0 Mil).

Hunan Jingfeng Pharmaceutical Co's annual additional paid-in capital increased from Dec. 2021 (¥1,016.6 Mil) to Dec. 2022 (¥1,016.9 Mil) but then stayed the same from Dec. 2022 (¥1,016.9 Mil) to Dec. 2023 (¥1,016.9 Mil).

Hunan Jingfeng Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Hunan Jingfeng Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jingfeng Pharmaceutical Co Additional Paid-In Capital Chart

Hunan Jingfeng Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1,007.99

1,016.60

1,016.93

Hunan Jingfeng Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															-	1,016.93	-	1,016.93	-

Hunan Jingfeng Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Hunan Jingfeng Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Hunan Jingfeng Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jingfeng Pharmaceutical Co Ltd (SZSE:000908) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Zhangyang Road, Pudong New District, 30th Floor, China Resources Times Square, Shanghai, CHN

Website

http://www.jfyiyao.com

Hunan Jingfeng Pharmaceutical Co Ltd is engaged in the manufacturing of pharmaceutical products in China. The company offers Chemical medicine, Biological medicine, and Traditional Chinese medicine. Some of its products include Lemai Wan, Analgesic, Fuping Capsules, and Tongdi Capsules among others.

Executives

Zhou Shen Dong	Supervisors
Ye Xiang Wu	Directors, executives
Ma Xian Peng	Executives
Cong Shu Fen	Executives
Zhang Jun Guo	Executives
Jian Wei Guang	Directors, executives
Bi Yuan	Secretary, Director
Ou Yang Yan Li	Secretary, Director
Luo Li	Director
Luo Bin	Director
Li Tong	Directors, executives
Wei Ze Chun	Director
Tang Zhi	Executives
Ou Yang Chun Bao	Executives
Mao Hui	Executives

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Headlines

No Headlines